spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

2019 PDA Annual Meeting

PDA Annual Meeting - USA

11-13 March 2019
Marriot Marquis San Diego, CA

Centered on the theme of Solving Manufacturing and Supply Challenges for Current and Future Medicinal Products, the 2019 PDA Annual Meeting is the premier venue for learning, benchmarking, and exploring the latest thinking with respect to innovation and continuous improvement in bio/pharmaceuticals.

Taking place over two and a half days in sunny San Diego, CA, this event has an agenda packed with the latest information on new technologies and therapies important to both small molecule and biopharmaceutical industries.

PDA is pleased to announce the following confirmed speakers:

  • Mike Thien, PhD, Senior Vice President of Operations, Manufacturing Systems Design and Commercialization, Merck & Co., Inc.
  • Nitin Rathore, PhD, Director of Core Technologies,Amgen Inc.
  • Gilad Langer, PhD, Vice President of Business Development,Bigfinite

Experts will share their insights during five plenary sessions, including:

  • From Bench to Bedside
  • Navigating the Global Regulatory Landscape
  • Accelerating Pharmaceutical Innovation
  • Bridging Current Technology with the Future of Medicine
  • Disaster Recovery/Business Continuity

Here’s what else you can look forward to at the Meeting:

  • Concurrent tracks on key industry topics, including innovative manufacturing strategies, disruptive technologies, supply chain complexity, and more.
  • Interest Group meetings offering in-depth discussion in key areas of interest
  • A packed Exhibit Hall showcasing the latest innovative technologies
  • Networking events, including activities specifically geared toward young professionals

Attend this flagship PDA meeting to investigate unique challenges, analyze current capabilities, and envision the possibilities of bio/pharmaceutical manufacturing!

Immediately following the Conference, on March 13-14, PDA will be hosting the 2019 PDA Practical Application of Sterile Manufacturing Workshop, exploring how companies are using innovative technologies to improve the quality, speed, and reliability of aseptic processing to ensure continued success in the production of sterile products.

Get the insider perspective on how the sterile manufacturing field is incorporating innovations in barrier technologies, implementing robotics, adopting rapid test methods, and tackling the challenges personalized medicine presents to conventional technologies.

On March 15, PDA will offer seven training courses on a variety of related topics as part of the 2019 Annual Meeting Training Course Series. Choose from the following training course options:

·        Preparing for Regulatory Inspections for the FDA and EMA

·        The Impact of CGMPs on Biomanufacturing Facility Design and Operation

·        Optimizing Human Factors to Improve Data Integrity

·        Clean Room Investigations

·        A Critical Thinking Approach to Improving Aseptic Process Manufacturing

·        Change Management – A Practical Workshop

·        Drug Device and Combination Product Risk Management and Safety Assurance Cases

Join PDA in San Diego for a full week of learning and networking opportunities to advance your knowledge and your career!

Visit pda.org/2019Annual and pda.org/2019Sterile to learn more!
phone (301) 656-5900 ext. 115
email registration@pda.org
web bit.ly/2Qu3IQJ
email Marriot Marquis San Diego, CA
 
Print this page
Send to a friend
   
spacer
Industry Events

SCOPE Europe – Summit for Clinical Ops Executives Europe

17-18 September 2019, Barcelona, Spain

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical innovation leaders, clin ops execs, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, five conference tracks, interactive breakout discussion groups, and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials.
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>


News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement